baber/WOPTO huggingface dataset:
Patent JP-2000509964-A (JP)
Title: 成長ホルモン生物活性に対して増強作用を有する生物活性分子、特にペプチド
IPC: A23K1/165
Filed: 1997-01-22
Abstract: (57)【要約】
成長ホルモンＧＨの１０４位と１１３位との間の配列、もしくはそれと交叉反応性を有する相同性を持つ配列の全てもしくは一部を含むペプチド構造体が開示される。ペプチドフラグメントは、輸送体ペプチド及び／またはアジュバントに共有結合により結合されており、上記成長ホルモンの生物学的活性のインビボでの増強効果を有し得る。
Patent JP-H09511980-A (JP)
Title: 非化学量論的タングステンカーバイド
IPC: C01B32/949
Filed: 1995-04-13
Abstract: (57)【要約】
炭素とタングステン間の原子比が０．５〜２を有するタングステンおよび炭素ベースの水素添加反応に有用な化合物で、この比は、同一の範囲で（タングステンおよび炭素の）如何なる与えられた化合物の化学量論比で少なくとも１％だけ相違する。前記化合物を準備ための方法は、（ａ）１５０〜１０００℃、好ましくは４００〜６００℃で、有利には少なくとも約１時間加熱することによってタングステン酸化物反応条件下で不活性ガス中、好ましくは窒素中で行われる予備プロセス工程；（ｂ）水素および炭素含有体を好ましい温度６００〜１２００℃、より有利には９００〜１１００℃の温度で接触させることによって工程（ａ）で得られた化合物を還元／炭化する工程；（ｃ）前記化合物が水素と，任意の不活性ガス中で、６００〜１２００℃、有利には７００〜１１００℃、好ましくは７００〜９００℃の温度で接触させる任意の水素添加／デコーキングする工程；（ｄ）有利には５％より低く、好ましくは２％より高くない酸素量を有し、しかも前記化合物に不活性であるガスで０〜５０℃、好ましくは２０℃近傍の温度で前記化合物を、前記化合物がこれ以上半透明でなくなるまで接触させる任意の半透明還元工程、からなる任意の半透明にする還元工程からなる。この化合物は有機合成において有用である。
Patent JP-H09512488-A (JP)
IPC: B23C5/22
Filed: 1995-04-18
Abstract: A fastening arrangement for cutting inserts on insert holders for cutting machining of metals is arranged in such a way that it comprises parallel grooves (11) on the underside of the insert and ribs (4) on the insert holder (2), the ribs matching into the grooves. The cutting insert is screwed upon the holder, whereby a wedge effect is attained between the grooves and the ribs because the insert's underside does not abut against the plane part surfaces (7) between the ribs, and because the tops of the ribs are not in contact with the bottoms of the grooves.
Patent JP-H09502479-A (JP)
Title: ポリ（オキシアルキレン）ヒドロキシ芳香族カルバメートのマンニッヒ縮合生成物及びそれを含有する燃料組成物
IPC: C10L1/16
Filed: 1995-04-21
Abstract: (57)【要約】
式(III)：
 〔式中、Ｒは、水素、又は１〜６個の炭素原子を有する低級アルキルであり；Ｒ 1 は、水素、ヒドロキシ、低級アルキル、又は低級アルコキシであり；Ｒ 3 及びＲ 4 は、独立に、水素、又は低級アルキルであり；Ｒ 5 は水素、アルキル、フェニル、アラルキル、アルカリール、又は式（ａ）：
 （式中、Ｒ 6 は、アルキル、フェニル、アラルキル、又はアルカリールである）を有するアシル基であり；そしてｎは５〜１００の整数である〕の化合物と、アルデヒド、及びアンモニア、低級アルキルアミン、ポリアミン及びそれらの混合物から選択された窒素塩基との縮合により製造されたマンニッヒ縮合生成物。このマンニッヒ縮合生成物及びそれらの燃料可溶性塩は、エンジン付着物の防止及び抑制のための燃料添加剤として有用である。
Patent JP-H11502483-A (JP)
Title: 自動車の液圧式のブレーキ装置内に設けられた電磁弁
IPC: B60T13/68
Filed: 1996-02-22
Abstract: (57)【要約】
圧力が大きく低下した時でも電磁弁の確実な開放が保証されるようにしなければならない。電磁弁（１）は、磁石可動子（５）を有していて、この磁石可動子（５）は、この磁石可動子（５）内で長手方向摺動可能に収容されたプッシュロッド（２７）を備えている。プッシュロッド（２７）のつばには、一方では、磁石可動子（５）をプッシュロッド（２７）と共に、電磁弁の閉鎖位置内に移動させるための戻しばね（３６）が作用し、またこれとは反対側に作用する、磁石可動子（５）で支えられた圧縮コイルばね（３４）が作用する。圧縮コイルばね（３４）は、戻しばね（３６）のプレロードよりも大きいプレロードを有している。圧力低下時には、プッシュロッド（２７）に、磁石力の作用とは逆方向に向けられた液圧式の閉鎖力を生ぜしめることができる。従って電磁弁（１）が開放位置に切り換えられると、磁石可動子（５）が、可動子ストローク（Ｈ）が増大するのに伴って上昇する磁石力に基づいてプッシュロッド（２７）を、つば（３０）に作用することによって連行する前に、磁石可動子（５）は圧縮コイルばね（３４）のばね力に抗して部分ストローク（ｈ）を行う。この電磁弁は、自動車のための液圧式のブレーキ装置の、自動吸込み式の高圧ポンプ（２３）とマスタブレーキシリンダ（２２）との間の吸込み導管（２１）内に使用することができる。
Patent JP-H10500116-A (JP)
Title: 置換されたジアザシクロヘキサンジ（チ）オン
IPC: C07C255/50
Filed: 1995-05-05
Abstract: (57)【要約】
 Ｑ 1 、Ｑ 2 、Ｒ 1 、Ｒ 2 、Ｒ 3 、Ｒ 4 、Ｒ 5 、Ｒ 6 及びＲ 7 が本明細書に記載される意味を有する一般式（Ｉ）を有する新規な置換されたジアザシクロヘキサンジ（チ）オン類、並びにその製造方法、新規な中間体生成物及びその除草剤としての使用が開示される。
Patent JP-2000506724-A (JP)
Title: 植物プロトポルフィリノーゲンオキシダーゼをコードするｄｎａ分子およびその阻害物質耐性突然変異体
IPC: C12N15/09
Filed: 1997-02-27
Abstract: (57)【要約】
本発明は、ダイズ、コムギ、ワタ、テンサイ、ナタネ、イネおよびモロコシ由来の植物プロトポルフィリノーゲンオキシダーゼ（ｐｒｏｔｏｘ）酵素をコードする新規のＤＮＡ配列を提供する。また、本発明は除草剤許容性のｐｒｏｔｏｘ酵素の修飾体を教示する。本明細書で教示した除草剤許容性のｐｒｏｔｏｘ酵素を発現する植物も提供する。これらの植物は、天然ｐｒｏｔｏｘ遺伝子の耐性体への変異を介してｐｒｏｔｏｘ阻害物質に対する抵抗が得られるように組み換えてもよく、植物ｐｒｏｔｏｘ酵素由来の阻害物質耐性形をコードする遺伝子で形質転換してもよい。
Patent JP-2000506173-A (JP)
Title: 眼の光力学的治療による視力の改善
IPC: A61K41/00
Filed: 1997-02-25
Abstract: (57)【要約】
眼の状態、特に年齢関連性斑状変性のような不所望の血管新生によって特徴付けられる状態の光力学的治療（ホトダイナミックセラピー：photodynamictherapy）によって、処置された患者の視力を増大させる。
Patent JP-2001508848-A (JP)
IPC: E04C3/18
Filed: 1998-01-17
Abstract: In order to easily assemble a supporting structure, preferably in a detachable manner from easily handled elements, without having to take extensive additional measures, the invention provides for a wooden beam construction comprising connecting elements (13) fitted into the individual beams (11/17) and assembled with at least one connecting part (1).
Patent JP-2001511727-A (JP)
Title: 材料の光−開始された化学的架橋のための装置
IPC: B29C35/08
Filed: 1998-02-19
Abstract: (57)【要約】
本発明は、材料（２８）の光開始化学架橋のための装置に関する。成形品の１個以上を形成するために、材料は、光学的に透明な成形用型（２６）で取り囲まれている。この装置は、それにより材料が架橋を誘発する光により作用させられることができる少なくとも１個の光源(１２)、例えばパルス化された光源を有する。成形用型（２６）中で架橋される領域は、少なくも部分的に、光源（１２）と成形用型（２６）の間のビーム境界画定要素（２０；２２）により決定される。それは、光源（１２）と成形用型（２６）の間に、透明及び不透明表面部分を有するマスク（２０）を配置することにより達成することができる。マスク（２０）は、次いで成形用型（２６）で取り囲まれている材料上に投影レンズにより投影される。材料上のマスク（２０）の投影は、テレセントリックビーム経路で実施される。
Patent JP-2000510703-A (JP)
Title: 自給式生物学的指示器
IPC: C12Q1/18
Filed: 1997-05-12
Abstract: (57)【要約】
自給式生物学的指示器（Ａ）が、殺菌または消毒プロセスの効果を判定する。ダート（６８）は、キャップ（Ｃ）のフィン（３６Ａ〜３６Ｆ）の爪（５０Ｃ）に、リム（５８）によって係合されたシール（８０）を有する。ダートは、培地容器（Ｄ）内に成長培地（Ｆ）を封入するフォイルシール（８６）の真上に整合されたカッティングエッジ（７６）を有する。ダートは、接種胞子または他の微生物がペーパーディスク（７４）上の格納されている室（７２）を有する。微孔性膜（Ｇ）は、殺菌流体または消毒流体が通過して胞子と接触することを可能にする一方で室内の接種胞子を捕獲する。容器は、フィン（３６Ａ〜３６Ｆ）の爪（５０Ａ）にフランジ（５６）によって取り付けられる。微生物汚染除去プロセスが完了した後、キャップは培地容器に向かって強制的に押され、それによってリムとフランジとをそれぞれの爪から外し、爪（５０Ｂ）に取り付け、結果としてフォイルシールに穴を開け、ダートを培地容器内に封入し、且つダートと接種胞子とを成長培地内に浸漬する。
Patent JP-H11510040-A (JP)
Title: 高圧直流送電施設
IPC: H02H11/00
Filed: 1997-05-26
Abstract: (57)【要約】
高電圧直流送電用施設は、直流線路（ＤＬ）によって相互接続されている少なくとも２つのコンバータ・ステーションを有し、少なくとも１つのステーション（ＳＲ１）が、直流線路上の接地事故を検出するように、及び接地事故が検出されたとき、線路の電圧（Ｕ D ）及び電流（Ｉ D ）の低減を達成し、かつ、その後再始動を企図するように適応した線路保護装置（ＬＰ）を有する。この施設は、更に直流線路上の持久接地事故の検出用検出部材（ＦＤ）を有する。検出部材は、線路保護装置による介入の後に活性化される。検出間隔中、検出部材は、前記ステーションの１つ（ＳＲ１）に電流を線路に供給させる。検出部材は、線間電圧を検出し、線間電圧の成長を無事故線路の場合の相当する期待電圧成長と比較し、かつ、もし検出した電圧成長が前記期待された成長より小さいならば、施設の再始動を防止する。
Patent JP-2000501492-A (JP)
Title: ピストン式内燃機関
IPC: F16J9/14
Filed: 1998-01-28
Abstract: (57)【要約】
シリンダー（２）に設けられた少なくとも一つのピストン（１）を有するピストン式内燃機関、特に大型ディーゼルエンジンにおいて、前記ピストンは前記シリンダー（２）に当接し、個々に配分された溝（５）に受容された多数のピストンリング（３，４）を備えたピストンリングセットを有し、少なくとも一つのガス密閉性の、互いに係合する端部（９）を有するピストンリング（３）および／あるいは間隙（１０）を形成しながら互いに離間する端部を有する少なくとも一つの標準ピストンリング（４）が設けられ、少なくとも個々のガス密閉性ピストンリング（３）には少なくとも一つの別個に設けられた漏損口が配分されたピストン式内燃機関において、二つのピストンリング端部の間に設けられた間隙によって形成されたものではない漏損口（１１）が、対応するピストンリング（３）が磨耗する際に前記漏損口の有効な断面が変化するように形成される。このことにより、漏損容量を個々の場合の要求に適合させることが可能となる。
Patent NO-20052205-A (NO)
Inventor: SUNDE TROND
IPC: A47C27/20
Filed: 2005-05-04
Abstract: A mattress, preferably for use on a bed, comprising a plurality of springs ( 2 ) arranged in a mattress body. The mattress is characterized in that at least a part of the mattress body is formed of an insert element ( 5 ) of foam plastic material. This insert element is preferably positioned at the end of the mattress.
Patent NZ-202669-A (NZ)
Title: Container with initially sealed replaceable lid
Inventor: INGEMANN O
IPC: B65D17/40
Filed: 1982-12-01
Abstract: A container comprising a body (1) with a lid (2) initially sealingly engaged on the body. The lid is removable from the body to open the container and is replaceable to close the container. The body has a mouth with a strip (10) of annular extent secured to the lid, the body being provided with an annular weakening zone (6) or notch (7) in the vicinity of the strip where the mouth of the container is secured to the lid. The container is separable at the weakening zone to separate a part of the mouth and the lid together with the strip from the body, the weakening zone being positioned radially inwards of the strip and upon rupture of the weakening zone forming a locating surface for replacement of the lid on the body. Upon reclosure of the lid on the body, the locating surface engages a cooperating part (25) to hold the lid securely on the body such as by snap-engagement.
Patent NZ-204608-A (NZ)
Title: Indolizine derivatives and pharmaceutical and veterinary compositions
Inventor: ROSSEELS G
IPC: A61K31/55
Filed: 1983-06-16
Abstract: Indolizine derivatives corresponding to the general formula: <IMAGE>   and the pharmaceutically acceptable acid addition salts thereof, wherein: R represents a straight- or branched-chain alkyl radical having from 1 to 4 carbon atoms or a phenyl radical, R1 represents a straight- or branched-chain alkyl radical having from 1 to 6 carbon atoms, X1 represents hydrogen, chlorine, bromine, methyl or methoxy, A represents a radical of the formula:   <IMAGE>  in which X2 represents hydrogen, chlorine, bromine, methyl or methoxy, n represents 1 or 2, a process for preparing said derivatives, pharmaceutical or veterinary compositions containing at least one of said derivatives and a method of treating pathological syndromes of the heart by administration of at least one of said derivatives to a subject in need of such treatment.
Patent NZ-209074-A (NZ)
Title: Process for the preparation of insulin derivatives
Inventor: GRAU U
IPC: C07K14/62
Filed: 1984-08-01
Abstract: The invention relates to a process for the preparation of insulin derivatives of the formula I    <IMAGE>  (I)  in which R30 represents the radical of a neutral L-amino acid which can be genetically coded, X represents identical or different radicals of L-amino acids which can be genetically coded, at least one of which is a basic amino acid, it being possible for the C-terminal member to be homoserine-lactone, Y denotes Phe or H and n denotes 1, 2 or 3, by splitting of intermediates, proinsulin, preproinsulin or analogs thereof, which comprises carrying out the splitting reaction close to the isoelectric point of the insulin derivatives of the formula I in the presence of an aromatic hydroxy compound.
Patent NZ-211566-A (NZ)
Title: Apparatus and process for extruding dough; die slot oriented vertically
Inventor: STRAKA R
IPC: A21C3/04
Filed: 1985-03-25
Abstract: A dough guide is used to precisely control thickness of an expanding dough extrudate. The extrudate is forced through at least two vertical slots in an extrusion head, at relatively high pressure and at a temperature at least equal to the boiling temperature of water. The dough guide has three plates. A middle plate is fixed between the slots. Two movable plates are disposed on opposite sides of each slot from the middle plate. A threaded rod is used to selectively adjust the location of each of the movable plates. In alternative embodiments, any number of slots are used, each having two guides adjacent it. Any or all of the guides may be made selectively movable. A product called "crisp bread" may be made thereby.
Patent NZ-216254-A (NZ)
Title: Treating stone surface with acid conditioning composition; acid conditioning composition
Inventor: GEORGE R D
IPC: C04B41/52
Filed: 1986-05-21
Abstract: A process for treating a stone surface is disclosed. Stone floor surfaces, such as, marble and terrazzo, are treated with an acid conditioner followed by buffing with a crystallizing agent whereby a durable, high gloss finish is produced in situ on the floor surface.
Patent NZ-222386-A (NZ)
Title: 2-phenylimino-oxazolidines as herbicides
Inventor: WELLINGA KOBUS
IPC: A01N43/76
Filed: 1987-11-02
Abstract: The invention relates to a herbicidally and/or algicidally active compound of the general formula <CHEM>  wherein R1 is a substituted or non-substituted alkyl group having 1-6 carbon atoms, or an alkenyl or alkynyl group having 2-6 carbon atoms; R2 is a halogen atom; a nitro group; a cyano group; a substituted or non-substituted benzyl, phenyl, phenoxy, phenylthio, phenylsulphinyl, phenylsulphonyl or phenylsulphonyloxy group; or a halogenated or non-halogenated alkyl, alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl or alkylsulphonyloxy group having 1-4 carbon atoms; R3 is a hydrogen atom, a halogen atom, or an alkyl group having 1-4 carbon atoms; and  X is O or S; or a salt of this compound with an organic or inorganic acid.
Patent NZ-224539-A (NZ)
Title: Fluid injector valve: resilient diaphragm urged closed by spring
Inventor: WILLIAMS HAROLD R
IPC: B05B1/30
Filed: 1988-05-06
Abstract: A cassette (18) containing a group of sealed cells is used as a means for delivering doses of fluid to be injected into a sterilizing chamber (10). After the cassette (18) is automatically positioned over a piercing mechanism, the cassette is moved downwardly so that a cell is pierced. Fluid is then forced out of the cell by pneumatic pressure into an injector valve (22), which opens in a manner which does not adversely affect a vacuum within the chamber (10)
Patent NZ-230042-A (NZ)
Title: Thiazolo(5,4-b)azepine derivatives; pharmaceutical compositions and processes for preparation
Inventor: TETSUYA AONO
IPC: A61P3/06
Filed: 1989-07-21
Abstract: New thiazolo [5,4-b]azepine compounds represented by <CHEM> ,wherein R<1> is a hydrogen atom, an aliphatic group which may be substituted, a carboxylic acyl group which may be substituted or a sulfonic acyl group which may be substituted; R<2> is a hydrogen atom, an aromatic group which may be substituted or an aliphatic group which may be substituted, which are capable of e.g., inhibiting lipoperoxide formation.
Patent NZ-230581-A (NZ)
Title: Vegetable organ culture in an in vitro hypoxic system
Inventor: DE MARCH GHISLAINE
IPC: C12N5/00
Filed: 1989-09-06
Abstract: To produce substances of vegetable origin, a vegetable organ is implanted in a culture medium and is kept under hypoxia by immersion beneath a layer of oil and the substances produced are extracted from the organ, the medium and/or the oil.
Patent NZ-233228-A (NZ)
Title: Polyisocyanate prepolymer composition prepared from an isocyanate-reactive polymer and an excess of diphenylmethane diisocyanate composition: preparation of foams
Inventor: WATTS ARUN
IPC: C08G101/00
Filed: 1990-04-05
Abstract: The invention relates to a liquid isocyanate-containing prepolymer composition having an average isocyanate functionality greater than 2 and an NCO content of from 2 to 15 % by weight, as obtainable by reacting an isocyanate reactive polymer having an average nominal functionality of from 2 to 6 with a stoichiometric excess of a diphenylmethane diisocyanate composition containing at least 2 % by weight of 2,4'-diphenylmethane diisocyanate and having an average isocyanate functionality in the range from 2 to 2.3. The invention also relates to a method for preparing a polyurethane foam, which comprises reacting such a prepolymer composition with water.
Patent NZ-233624-A (NZ)
Title: 2,5-diazabicyclo(2.2.1)heptane derivatives, pyrrolidine derivatives and their preparation
Inventor: BRAISH TAMIN FEHME
IPC: C07D207/48
Filed: 1990-05-09
Abstract: Diazabicyclo[2.2.1]heptane intermediates are prepared from 4-hydroxy-L-proline in a five step procedure, or from allo-4-hydroxy-D-proline, through a novel 2-(C1-c6)alkyl-5-substituted-2,5-diazabicyclo[2.2.1]heptane intermediate. The diazabicycloheptanes are of use in the preparation of antibiotic quinolones.
Patent NZ-234980-A (NZ)
Title: Preparation of an emulsifying agent
Inventor: CASTLE EDWARD R
IPC: C09K23/30
Filed: 1990-08-20
Abstract: A process for the preparation of an emulsifying agent which comprises treating a biological material containing a lipid as well as a lipoprotein and/or a protein with a protease and a lipase and pasteurising the product. The biological material may also contain phospholipids such as lecithin and phospholipoproteins, e.g. egg yolk.
Patent NZ-235445-A (NZ)
Title: Human c3b/c4b receptor (cr1) gene, its encoded protein and pharmaceutical compositions
Inventor: FEARON DOUGLAS T
IPC: C12N15/12
Filed: 1990-09-25
Abstract: The present invention relates to the C3b/C4b receptor (CR1) gene and its encoded protein. The invention also relates to CR1 nucleic acid sequences and fragments thereof comprising 70 nucleotides and their encoded peptides or proteins comprising 24 amino acids. The invention further provides for the expression of the CR1 protein and fragments thereof. The genes and proteins of the invention have uses in diagnosis and therapy of disorders involving complement activity, and various immune system or inflammatory disorders. In specific embodiments of the present invention detailed in the examples sections infra, the cloning, nucleotide sequence, and deduced amino acid sequence of a full-length CR1 cDNA and fragments thereof are described. The expression of the CR1 protein and fragments thereof is also described. Also described is the expression of a secreted CR1 molecule lacking a transmembrane region. The secreted CR1 molecule is shown to be useful in reducing damage caused by inflammation and in reducing myocardial infarct size and preventing reperfusion injury.
Patent NZ-238333-A (NZ)
Title: Dough forming machine: rotating disc has rollers in spiral formation
Inventor: LARSEN HANS KURT
IPC: A21C11/00
Filed: 1991-05-30
Abstract: A machine for the automatic forming of dough based product comprising a conveyor belt (11) above which is a reciprocating punch die (13) fitted with a cutter (15) shaped to conform to the perimeter of the desired dough product and beneath which is a rotating disc (18) provided on its upper surface with a plurality of small rollers (21) arranged to form at least one spiral which rollers (21) are adapted to press against the lower side of the conveyor belt (11) when the punch die descends. <IMAGE>
Patent NZ-250852-A (NZ)
Title: Packaging machine for filling and sealing containers, with replaceable workstations and infeed conveyor extending partly in parallel with main convevor
Inventor: STARK OLOF
IPC: B65B3/12
Filed: 1994-02-09
Abstract: Packaging machine for manufacturing filled and sealed packaging containers (32), said machine including an endless conveyor (2) along which are disposed replaceable machine modules (16,17,18). Each of the modules is driven by an individual motor (24,28). The different motors are controlled by a common control unit. Along the conveyor are disposed a first station (16) where the containers are transferred and bottom-sealed and a second station (17,18) for top-sealing of the containers. <IMAGE>
Patent NZ-260456-A (NZ)
Title: Bolt bearing tab engages gland of machine housing in tenon/mortise type joint : tab bolt-bearing and side gland engaging surfaces forming obtuse angle
Inventor: AZIBERT HENRI V
IPC: F16J15/16
Filed: 1991-11-08
Abstract: A universal gland having a central opening for mounting coaxially about a machine shaft and adapted for mounting to a machine housing (55), through which the shaft extends, by a plurality of bolts (50) at bolt hole positions in the housing, characterized in that the gland comprises a gland body (12, 14) extending radially at the bolt hole positions a distance less than the minimum radial distance of the bolt hole positions from the axis of the shaft the gland further comprises a plurality of bolt mounting tabs (30) extending radially beyond the periphery of the gland body a distance at least to the bolt hole positions the tabs are angularly adjustable about the gland body; and the gland body comprises a mounting surface (16) for placement adjacent the housing and facing away from the mounting surface at least one tab engaging surface (25) engaged by the tabs for transferring forces from the bolts to the gland body is disclosed. <IMAGE>
Patent NZ-262634-A (NZ)
Title: Stabilizing polypeptides against degradation by organic solvents by admixing the peptide with trehalose or mannitol
Inventor: CLELAND JEFFREY L
IPC: A61K38/00
Filed: 1994-02-17
Abstract: PCT No. PCT/US94/01666 Sec. 371 Date Apr. 8, 1994 Sec. 102(e) Date Apr. 8, 1994 PCT Filed Feb. 17, 1994 PCT Pub. No. WO94/19020 PCT Pub. Date Sep. 1, 1994Methods for excipient stabilization of dry or aqueous polypeptides treated with organic solvents are disclosed, wherein the polypeptide is admixed with trehalose, a polyol having a molecular weight less than about 70,000 kD.
Patent NZ-270694-A (NZ)
Title: Liquid coffee extracts; hydrolysis of galactomannans therein
Inventor: NICOLAS PIERRE
IPC: C12P19/14
Filed: 1995-03-13
Abstract: Hydrolysis of galactomannans in a liq. coffee extract, with immobilised  beta -mannanase (BM) at 20-80 degrees C, is new.
Patent NZ-270951-A (NZ)
Title: Electrofusion coupler; comprises a sleeve of thermoplastics material with sockets for plastics pipe parts to be connected, the sleeve incorporating electrically conductive pins, elements and electrical resistance heater winding
Inventor: BARFIELD MALCOLM RAYMOND
IPC: B29D23/00
Filed: 1995-04-19
Abstract: In the manufacture of an electrofusion coupler, a winding (2) of an electrical resistance heating wire is wound directly around a mandrel (10) which comprises two parts providing respective ends of the mandrel. The mandrel supports electrically conducting terminal elements (5,6) by means of supporting locations (11) on the mandrel parts which form an integral part of the mandrel. The resistance wire (2) wound around the mandrel is connected to the electrically conducting terminal elements (5,6). Subsequently a body of thermoplastics (1) is moulded around the mandrel to form the electrofusion coupler, and thereafter the mandrel parts are extracted axially from the electrofusion coupler from opposite ends, leaving the winding (2) and terminal elements (5,6) in place in the electrofusion coupler. In a variant, a thermoplastic preform (3) is manufactured having electrically conducting terminal plates (5) secured thereto, the preform having an electrical resistance heating wire (2) wound therearound and secured to said terminal plates. An outer thermoplastics jacket (1) is then moulded around the wound preform (3) and said terminal plates (5), with bores being formed in said outer jacket extending to holes in the terminal plates. Subsequently electrical terminals having screw-threaded shanks (9) are screwed into said bores and into electrical contact with said terminal plates (5). <IMAGE>
Patent NZ-280662-A (NZ)
Title: 1-alkyl-5-acyl-1,4-dihydropyridines and medicaments
Inventor: URBAHNS KLAUS
IPC: C07D211/82
Filed: 1995-12-13
Abstract: The use of 1-alkyl-3,5-diacyl-2,6-dimethyl-6-aryl-1,4-dihydropyridines of formula (I) is claimed in the prepn. of selective potassium channel modulating medicaments for treating CNS disorders. R1 = 6-10C aryl (opt. substd. by 1-5 of NO2, CN, halogen, CF3 and 1-6C alkylthio); R2 = 1-8C alkyl, phenyl, 1-8C alkoxy or phenoxy; R3 = 1-8C alkyl or phenyl; R4 = 1-4C alkyl. The following cpds. (I) are new: 1-(5-acetyl-4-(R')-1,2,6-trimethyl-1,4-dihydropyridin-3-yl)-ethanone; and 5-acetyl-4-(R")-1,2,6-trimethyl-1,4-dihydropyridine-3-carboxylic acid methyl ester. R' = 2,4,5-, 2,3,5- or 3,4,5-trichlorophenyl, 2,3- or 3,4-dichlorophenyl, 4-chlorophenyl or 4-fluorophenyl; R" = 4-chlorophenyl, 2,3- or 3,4-dichlorophenyl, 3- or 4-nitrophenyl, 3,4,5-trifluorophenyl, 4-fluorophenyl or 4-chloro-3-trifluoromethylphenyl. The prepn. of new and known (I) is claimed (see 'Preparation').
Patent NZ-282440-A (NZ)
Title: Determining electricity charges by determining profile indicating variation in consumption over sub-periods
Inventor: WILLIAMS PAUL NICHOLAS
IPC: G01R21/133
Filed: 1995-03-22
Abstract: PCT No. PCT/GB95/00636 Sec. 371 Date Jan. 6, 1997 Sec. 102(e) Date Jan. 6, 1997 PCT Filed Mar. 22, 1995 PCT Pub. No. WO95/26065 PCT Pub. Date Sep. 28, 1995An apparatus associated with a public electricity distribution network to determine charges for the supplied electricity where the period during which consumption is measured (the metered period) is longer than the period used for settling the price or value of the electricity (the settlements period) and where the charge can be determined for either the metered period or the settlements period. The apparatus further provides means for adjusting charges such that the total charges equals the total owed or that total minus a defined amount. Means are also provided whereby the apparatus does not require metered data from all consumers connected to the network. The apparatus also provides means for determining the value of the supplied electricity where a plurality of generation sites exist each of which separately valued.